Indeed, in a mouse prostate non-invasive tumor model induced by PTEN deletion, outer tumor cells only were preserved in mice treated with mTOR inhibitors and residual tumor cells were BCL2-positive.44 The extent to which these protected niches are relevant to human tumors treated with targeted-therapies warrants future investigation. Here, MTOR is linked to neoplasm.